Citius Oncology Cash Flow Statement (2023-2026) | CTOR

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.15M-0.20M-4.81M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Share-based Compensation (Quarter) 1.92M3.87M5.83M11.59M1.81M2.09M2.13M2.30M3.96M3.70M
Deferred Taxes (Quarter) 0.14M0.29M0.43M0.26M0.26M0.26M0.26M0.26M-0.23M
Cash from Operations (Quarter) -0.17M-0.10M-0.38M-0.19M-0.37M-7.35M-3.83M
Change in Working Capital
Change in Receivables (Quarter) 4.05M-2.97M
Change in Inventory (Quarter) 6.11M0.96M1.87M3.71M0.35M0.02M
Change in Account Payables (Quarter) -1.08M-0.79M-1.29M2.31M2.05M0.60M4.57M-2.79M1.50M
Change in Accured Expenses (Quarter) 0.02M0.07M0.36M-0.20M-0.26M0.19M6.23M2.49M-0.26M-4.37M0.43M19.54M
Investing Activities
Cash from Investing Activities (Quarter) -0.66M24.74M0.07M-4.40M-0.60M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.78M0.20M0.33M
Change in Capital Stock
Shares Issued (Quarter) 12.60M12.75M4.75M5.14M5.55M18.10M18.10M18.10M
Net Equity Issued and Repurchased (Quarter) 15.17M15.13M-0.06M
Misc.
Cash from Financing Activities (Quarter) 0.78M-24.55M0.26M15.13M-0.23M
Change in Cash (Quarter) -0.17M0.25M-0.26M584.00-0.03M3.37M-4.66M
Free Cash Flow (Quarter) -0.17M-0.10M-0.38M-0.19M-0.37M-7.35M-3.83M
Net Cash Flow (Quarter) -0.17M-0.10M-0.26M584.00-0.03M3.37M-4.66M